Cargando…
Long-term outcome of targeted therapy of underlying conditions in patients with early persistent atrial fibrillation and heart failure: data of the RACE 3 trial
AIMS: The Routine vs. Aggressive risk factor driven upstream rhythm Control for prevention of Early persistent atrial fibrillation (AF) in heart failure (HF) (RACE 3) trial demonstrated that targeted therapy of underlying conditions improved sinus rhythm maintenance at 1 year. We now explored the ef...
Autores principales: | Nguyen, Bao Oanh, Crijns, Harry J G M, Tijssen, Jan G P, Geelhoed, Bastiaan, Hobbelt, Anne H, Hemels, Martin E W, Mol, W J Myke, Weijs, Bob, Alings, Marco, Smit, Marcelle D, Tieleman, Robert G, Tukkie, Raymond, Van Veldhuisen, Dirk J, Van Gelder, Isabelle C, Rienstra, Michiel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282914/ https://www.ncbi.nlm.nih.gov/pubmed/34791160 http://dx.doi.org/10.1093/europace/euab270 |
Ejemplares similares
-
Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study
por: Al-Jazairi, Meelad I H, et al.
Publicado: (2021) -
Effects of a simple cardiac rehabilitation program on improvement of self-reported physical activity in atrial fibrillation – Data from the RACE 3 study
por: Nguyen, Bao Oanh, et al.
Publicado: (2020) -
Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study
por: Alings, M., et al.
Publicado: (2013) -
Number of comorbidities is associated with symptom severity and arrhythmia progression in paroxysmal atrial fibrillation - Data from the RACE V study
por: Van De Lande, M E, et al.
Publicado: (2023) -
Time of onset of atrial fibrillation and atrial fibrillation progression data from the RACE V study
por: van de Lande, Martijn E, et al.
Publicado: (2023)